Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1995
|
| gptkbp:ATCCode |
L04AD01
|
| gptkbp:brand |
gptkb:cyclosporine
|
| gptkbp:contraindication |
uncontrolled hypertension
malignancies |
| gptkbp:form |
oral solution
soft gelatin capsule |
| https://www.w3.org/2000/01/rdf-schema#label |
Neoral
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
immunosuppressant
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
hypertension
nephrotoxicity hirsutism gingival hyperplasia |
| gptkbp:status |
FDA approved
|
| gptkbp:usedFor |
prevention of organ transplant rejection
treatment of psoriasis treatment of rheumatoid arthritis |
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|